Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting
C. Zengarini
Dermatology, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
Search for more papers by this authorCorresponding Author
A. Guglielmo
Dermatology, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
*Correspondence: A. Guglielmo. E-mail: [email protected]
Search for more papers by this authorM. Giovani
Dermatology, Azienda Ospedaliera-Universitaria di Modena, Modena, Italy
Dermatology, Dipartimento Chirurgico, Medico, Odontoiatrico e di Scienze Morfologiche con Interesse Trapiantologico, Oncologico e di Medicina Rigenerativa, University of Modena, Modena, Italy
Search for more papers by this authorC. Preci
Dipartimento cure primarie, AUSL Modena, Modena, Italy
Search for more papers by this authorE. Dika
Dermatology, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
Search for more papers by this authorB.M. Piraccini
Dermatology, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
Search for more papers by this authorA. Pileri
Dermatology, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
Search for more papers by this authorC. Zengarini
Dermatology, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
Search for more papers by this authorCorresponding Author
A. Guglielmo
Dermatology, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
*Correspondence: A. Guglielmo. E-mail: [email protected]
Search for more papers by this authorM. Giovani
Dermatology, Azienda Ospedaliera-Universitaria di Modena, Modena, Italy
Dermatology, Dipartimento Chirurgico, Medico, Odontoiatrico e di Scienze Morfologiche con Interesse Trapiantologico, Oncologico e di Medicina Rigenerativa, University of Modena, Modena, Italy
Search for more papers by this authorC. Preci
Dipartimento cure primarie, AUSL Modena, Modena, Italy
Search for more papers by this authorE. Dika
Dermatology, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
Search for more papers by this authorB.M. Piraccini
Dermatology, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
Search for more papers by this authorA. Pileri
Dermatology, IRCCS of Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Dermatology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
Search for more papers by this author
References
- 1Gaspari V, Orioni G, Misciali C, Viviani F, Zengarini C. COVID-19 skin eruptions: incidence in hospitalized patients in Bologna. Int J Dermatol 2021; 60: 512–513.
- 2Wang D, Hu B, Hu C et al. Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069.
- 3Martinez-Lopez A, Cuenca-Barrales C, Montero-Vilchez T, Molina-Leyva A, Arias-Santiago S. Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: a guide for the dermatologist. J Am Acad Dermatol 2020; 83: 1738–1748.
- 4Gilad V, Masoero G. Treatment of COVID-19 patients in Italy: a physician's experience and insights. Rambam Maimonides Med J 2020; 11: e0028.
- 5Daneshgaran G, Dubin DP, Gould DJ. Cutaneous manifestations of COVID-19: an evidence-based review. Am J Clin Dermatol 2020; 21: 1–13.
- 6Goujon A, Natale F, Ghio D, Conte A. Demographic and territorial characteristics of COVID-19 cases and excess mortality in the European Union during the first wave. J Popul Res 2021; 1–24.
- 7Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 2020; 34: e212–e213. https://doi.org/10.1111/jdv.16387